The western blot results showed that the expression of Gli1, but not Gli2 or Gli3, was dramatically increased in USP44-downregulated HCC cells (Fig. 3E, Supplementary Fig. 1B). This evidence concerns the gene GLI2 and hepatocellular carcinoma.